Applying the Kessler Foundation Modified Story Memory Technique to Improve New Learning in Aging Populations.

IF 1.4 Q4 CLINICAL NEUROLOGY
Dementia and Geriatric Cognitive Disorders Extra Pub Date : 2025-02-05 eCollection Date: 2025-01-01 DOI:10.1159/000543682
Nancy D Chiaravalloti, Erica Weber, Silvana L Costa, Jean Lengenfelder, Diana Maloku, Nancy B Moore, John DeLuca
{"title":"Applying the Kessler Foundation Modified Story Memory Technique to Improve New Learning in Aging Populations.","authors":"Nancy D Chiaravalloti, Erica Weber, Silvana L Costa, Jean Lengenfelder, Diana Maloku, Nancy B Moore, John DeLuca","doi":"10.1159/000543682","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The current study examined the efficacy of the 10-session Kessler Foundation modified Story Memory Technique (KF-mSMT<sup>®</sup>) to improve new learning in older adults.</p><p><strong>Methods: </strong>This double-blind, placebo-controlled randomized clinical trial included twenty-eight individuals over age 65 randomized to the treatment group (<i>n</i> = 17) or placebo control group (<i>n</i> = 13). Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory, and a repeat assessment immediately post-treatment. The primary outcome measure was the total learning score from the California Verbal Learning Test II (CVLT-II) and the secondary outcome measure was the total score from the Memory Functioning Questionnaire.</p><p><strong>Results: </strong>A significant effect of the KF-mSMT<sup>®</sup> was noted on the CVLT-II total learning score in the treatment group, demonstrating a large effect size. Post hoc analysis examining benefit from the KF-mSMT<sup>®</sup> in the healthy aging group as compared with the mild cognitive impairment (MCI) group showed a trend toward significance (<i>p</i> = 0.069), with a large effect size. With benefit defined as a 10% or greater improvement in the CVLT total learning, 65% of patients in the treatment group showed improvement from baseline to immediate follow-up, compared with 31% of the control group (<i>p</i> = 0.06). Significant treatment effects were also noted in a self-report measure of memory in daily life, the Memory Functioning Questionnaire. Post-treatment changes in depression or anxiety from before to after treatment were not significant between the groups.</p><p><strong>Conclusion: </strong>The current study presents preliminary evidence in support of the KF-mSMT<sup>®</sup> for improving learning and memory abilities in older populations of those aging normally and those meeting criteria for MCI.</p>","PeriodicalId":38017,"journal":{"name":"Dementia and Geriatric Cognitive Disorders Extra","volume":"15 1","pages":"37-46"},"PeriodicalIF":1.4000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11908804/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Dementia and Geriatric Cognitive Disorders Extra","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000543682","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The current study examined the efficacy of the 10-session Kessler Foundation modified Story Memory Technique (KF-mSMT®) to improve new learning in older adults.

Methods: This double-blind, placebo-controlled randomized clinical trial included twenty-eight individuals over age 65 randomized to the treatment group (n = 17) or placebo control group (n = 13). Participants completed a baseline neuropsychological assessment, including questionnaires assessing everyday memory, and a repeat assessment immediately post-treatment. The primary outcome measure was the total learning score from the California Verbal Learning Test II (CVLT-II) and the secondary outcome measure was the total score from the Memory Functioning Questionnaire.

Results: A significant effect of the KF-mSMT® was noted on the CVLT-II total learning score in the treatment group, demonstrating a large effect size. Post hoc analysis examining benefit from the KF-mSMT® in the healthy aging group as compared with the mild cognitive impairment (MCI) group showed a trend toward significance (p = 0.069), with a large effect size. With benefit defined as a 10% or greater improvement in the CVLT total learning, 65% of patients in the treatment group showed improvement from baseline to immediate follow-up, compared with 31% of the control group (p = 0.06). Significant treatment effects were also noted in a self-report measure of memory in daily life, the Memory Functioning Questionnaire. Post-treatment changes in depression or anxiety from before to after treatment were not significant between the groups.

Conclusion: The current study presents preliminary evidence in support of the KF-mSMT® for improving learning and memory abilities in older populations of those aging normally and those meeting criteria for MCI.

应用Kessler基金会改良的故事记忆技术提高老年人的新学习能力。
目前的研究考察了10期Kessler基金会改良故事记忆技术(KF-mSMT®)对改善老年人新学习的效果。方法:这项双盲、安慰剂对照的随机临床试验包括28名65岁以上的患者,随机分为治疗组(n = 17)和安慰剂对照组(n = 13)。参与者完成了基线神经心理学评估,包括评估日常记忆的问卷,以及治疗后立即进行的重复评估。主要结果测量是加州语言学习测试II (CVLT-II)的总学习分数,次要结果测量是记忆功能问卷的总得分。结果:KF-mSMT®对治疗组CVLT-II总学习成绩有显著影响,显示出较大的效应量。事后分析显示,与轻度认知障碍(MCI)组相比,健康老年组从KF-mSMT®中获益的趋势具有显著性(p = 0.069),效应量较大。获益定义为CVLT总学习改善10%或更高,治疗组65%的患者从基线到立即随访均有改善,而对照组为31% (p = 0.06)。在日常生活记忆的自我报告测量中,记忆功能问卷也注意到显著的治疗效果。治疗前后抑郁或焦虑的变化在两组间无显著差异。结论:目前的研究提供了初步证据,支持KF-mSMT®在正常衰老的老年人和符合MCI标准的老年人中改善学习和记忆能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Dementia and Geriatric Cognitive Disorders Extra
Dementia and Geriatric Cognitive Disorders Extra Medicine-Psychiatry and Mental Health
CiteScore
4.30
自引率
0.00%
发文量
18
审稿时长
9 weeks
期刊介绍: This open access and online-only journal publishes original articles covering the entire spectrum of cognitive dysfunction such as Alzheimer’s and Parkinson’s disease, Huntington’s chorea and other neurodegenerative diseases. The journal draws from diverse related research disciplines such as psychogeriatrics, neuropsychology, clinical neurology, morphology, physiology, genetic molecular biology, pathology, biochemistry, immunology, pharmacology and pharmaceutics. Strong emphasis is placed on the publication of research findings from animal studies which are complemented by clinical and therapeutic experience to give an overall appreciation of the field. Dementia and Geriatric Cognitive Disorders Extra provides additional contents based on reviewed and accepted submissions to the main journal Dementia and Geriatric Cognitive Disorders Extra .
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信